This website uses cookies to ensure you get the best experience on our website. Learn more
Meet the team
We are a world-class team with experience across diagnostic, medical technology, therapeutic, and technology sectors.
Leadership team
Marcel Gehrung PhD
Co-founder & Chief Executive Officer
Neha Goel
Chief Operating Officer
Robin Barclay
Chief Business Officer
Chris Humberston
VP of Finance
Neil Ryan
VP Laboratory Services
Mark Horsburgh PhD
VP Software Engineering
Stephanie Juniat
Director of Commercial & Access Strategy
Basirat Afinowi
Head of Projects
Rich Arnatt
Head of Product
Sarah Killcoyne PhD
Head of Research & Development
Charlene Tang
Head of Growth
Jack Wilson
Head of People
Prof. Rebecca Fitzgerald FMedSci OBE
Co-founder & Clinical Advisor
Dr Maria O'Donovan MB BCH, MD, FRCPath
Co-founder & Lead Pathologist
Will West
Chairman
Anthony Aiudi
Investor Director
Martin Frost CBE
Non-Executive Director
Tim Rea
Investor Director
Marcel Gehrung PhD
Co-founder & Chief Executive Officer
Marcel holds a PhD in Machine Learning in Healthcare from the University of Cambridge. Marcel was named on the Forbes 30 under 30 list, won the Alexander Fleming Prize from the Gates Foundation for his contribution to global public health and the Prix Galien Award for the best medical technology with Cyted’s core product, a novel test for the early detection of cancer in the oesophagus.
Close
Neha Goel
Chief Operating Officer
Neha leads operational and laboratory services, and quality and regulatory functions at Cyted building infrastructure and processes that enable growth and improve efficiency.
Neha has 15 years of experience in innovative healthcare. She brings an in depth understanding of product development, manufacturing, scale up, clinical evaluations, implementation and roll out from various posts at Diagnostics for the Real World and the University of Cambridge.
Robin Barclay
Chief Business Officer
Robin leads our day-to-day operations encompassing Commercial, Product, Technology, Finance, People & Partnership management.
Robin has a 20+ year career in Commercial and Delivery roles in Health Technology & Health IT domains including Oncology Decision Support, Primary Care, Radiology, Cardiology and Intensive Care. He has experience in both corporate and start up environments.
Chris Humberston
VP of Finance
Chris is responsible for the day-to-day finances at Cyted, implementing a strong financial control and reporting framework across the business. He collaborates with key internal and external stakeholders to drive Cyted’s commercial and financial strategy.
Chris has worked in finance for nearly a decade, developing a strong skill set within an M&A and audit practice environment. He is an ACA chartered accountant who has significant experience in financial planning and decision-making to help deliver business strategy.
Neil Ryan
VP Laboratory Services
Neil leads laboratory operations and outputs. Neil is helping Cyted deliver on our strategic goals by ensuring processes are designed to scale effectively whilst retaining diagnostic quality and integrity.
Neil has over 20 years experience working within cellular and molecular pathology across sectors. He has performed senior leadership and Board level roles, most recently within private healthcare diagnostics businesses. Alongside his role at Cyted, Neil also operates as Non-Exec Director for UKNEQAS CPT.
Mark Horsburgh PhD
VP Software Engineering
Mark leads the software engineering team at Cyted. He is responsible for the development of our operational software, integration points with customers, and the machine learning platform.
Mark has over 20 years of experience in building software products and software engineering teams in both startup and large multinational corporations.
Stephanie Juniat
Director of Commercial & Access Strategy
Stephanie leads Cyted’s business development activities relating to the commercial launch and growth of Cyted's innovative diagnostic test into new markets and new indications. She is experienced in the commercialisation of life science products in international markets, having worked on medical devices, therapeutics, diagnostics and AI covering US, Canada, Europe, Africa, SE Asia, South America and Australia. Past experiences include Pfizer, the Wellcome Trust, and Huron Consulting Group.
Close
Basirat Afinowi
Head of Projects
Basirat leads the Project Management function at Cyted, entrusted with overseeing and orchestrating the successful execution of strategic initiatives.
Basirat has over a decade's proven track record in project management across diverse sectors including the public sector, higher education, and not-for-profit organisations. With a passion for driving impactful change and achieving organisational excellence, she has dedicated her career to delivering successful projects that address complex challenges.
Rich Arnatt
Head of Product
Rich leads the Product function at Cyted, encompassing product management, research and design. Responsible for Cyted’s product roadmap and ensuring that cross-functional teams are aligned towards our strategic goals.
Rich is an experienced technology and innovation professional with a background in industrial analytics. Prior to joining Cyted, he held a number of Product, Engineering and Innovation roles delivering complex, global solutions across multiple markets and domains.
Sarah Killcoyne PhD
Head of Research & Development
Sarah leads the Research and Development work at Cyted across molecular characterization, statistical modeling, and image-based machine learning to build new tests for early cancer detection.
Sarah has more than 15 years experience in cancer research and genomics analysis across biotech and academic institutions in both the USA and U.K. Her focus since 2016 has been on the early detection of cancer using molecular risk analysis and deep learning methods and applying these methods to the detection of esophageal cancer. Her work in this area has been published in Nature Medicine, The British Journal of Cancer, and Lancet Oncology.
Charlene Tang
Head of Growth
Charlene leads business development and commercial strategy at Cyted focused on the UK. As a Fellow at the NHS Innovation Accelerator, Charlene focuses on building partnerships with NHS organisations and other healthcare providers towards national adoption and customer success.
Over the past 2 years, Charlene has developed proposals and built teams to win and deliver ~£4m in grant funding towards the real-world implementation of the capsule sponge test in primary care and community based clinics, driving adoption and care transformation.
Jack Wilson
Head of People
Jack leads the People team enabling the business to scale and grow, defining the people programme and strategic workforce plan whilst ensuring this aligns closely with business strategy.
Jack is a delivery driven People Operations Manager with broad experience across VC & PE backed businesses. Jack is strategic and innovative, translating business strategy into People and Operational initiatives that enable businesses to scale and grow.
Prof. Rebecca Fitzgerald FMedSci OBE
Co-founder & Clinical Advisor
Director of the Early Cancer Institute at the University of Cambridge and a Clinician Scientist leading her own research in understanding and detecting cancers of the oesophagus and stomach at an earlier stage. Rebecca and her team developed the Cytosponge-TFF3 test from concept through to clinical trial and implementation. She is a Trustee for Heartburn Cancer UK, a Charity supporting awareness and education into cancer of the oesophagus and its precursor Barrett’s oesophagus.
Close
Dr Maria O'Donovan MB BCH, MD, FRCPath
Co-founder & Lead Pathologist
Consultant Histopathologist at Cambridge University Hospital NHS Trust (CUH) where she is the lead for diagnostic cytology and upper gastrointestinal cancer pathology services. Dr O'Donovan is a co-director of East of England Pathology courses. Her primary research interest is in cancer of the esophagus and. stomach. She received the Royal College of Pathologists Achievement award 2021 for innovation in pathology practice.
Will West
Chairman
Biotechnology Chief Executive, Director and Chair, with experience spanning basic research through to late-stage clinical trials.
Close
Anthony Aiudi
Investor Director
Investment professional at Morningside, providing operational and managerial oversight and expertise to early-stage biotechnology companies.
Close
Martin Frost CBE
Non-Executive Director
Commercially-driven leader and advisor of purpose-driven global technology businesses, having worked across Medtech, Technology and FinTech sectors.
Close
Tim Rea
Investor Director
Investor at BGF, with a focus on tech-oriented propositions. Tim holds multiple board positions and has a wealth of experience in venture capital and start-up ecosystems.
CloseIn partnership with
Find out how we are
